Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSFOMYCIN vs FREMANEZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSFOMYCIN vs FREMANEZUMAB: Safety Overview

Metric FOSFOMYCIN FREMANEZUMAB
Total FAERS Reports 828 224
Deaths Reported 128 2
Death Rate 15.5% 0.9%
Hospitalizations 407 39
Average Patient Age 55.3 yrs 47.1 yrs
% Female Patients 57.3% 88.8%
FDA Approval Date Oct 22, 2025 N/A
Manufacturer Meitheal Pharmaceuticals Inc. Teva Pharmaceuticals USA, Inc.
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription N/A